Outcomes of Patients Requiring Venoarterial Extracorporeal Membrane Oxygenation (VA-ECMO) for Cardiogenic Shock and Evaluation of Programmatic Changes
Authors' conclusion
This study identifies a current mortality rate for patients with cardiogenic shock requiring VA-ECMO at 23.9%. This rate is lower than previously reported and coincides with beneficial programmatic changes to an ECMO program.
Study context
- Population
- Adults with cardiogenic shock requiring VA-ECMO at a tertiary care medical center, January 2012 to January 202546 in 2020–2025 era
- Participants
- 134 adults
- Exposure
- Outcomes of VA-ECMO for cardiogenic shock across two eras
- Outcome
- Mortality, January 2020 to January 2025 era
Methodological detailssingle tertiary care centre
- Single tertiary care centre
Main finding
As reported in the abstract
Overall mortality rate, 2020–2025 (n = 46)
23.9%
Observational data: associations, not effects.
Further findings
Hospital LOS, survivors vs nonsurvivors
P = 0.001
Survival to discharge, January 2012 to January 2025
- Survival to discharge (n = 73)
- 50%
Characteristics associated with mortality
- Procedure type
- P = 0.025
- RBC
- P = 0.037
- FFP
- P = 0.030
- Platelets
- P = 0.044
- Cryoprecipitate
- P = 0.001
- Longer CPB time
- P = 0.005
Survival, heart transplantation subset (n = 22)
- Survived (20 patients)
- 90.1%
Parts of this Brief are withheld: the automatic checks could not confirm them against the abstract.
Original publication
Outcomes of Patients Requiring VA-ECMO for Cardiogenic Shock and Evaluation of Programmatic Changes. J Cardiothorac Vasc Anesth. Published 22 April 2025. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →